← Back to All Filings

AEHR Test Systems Director Files Intent to Sell $66k in Stock

Low SignificanceOctober 9, 2025 at 3:03:44 PM EDT

AEHR TEST SYSTEMS

$AEHR144CIK: 0001040470

Subscribe to track AEHR

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

AEHR Director Files Intent to Sell $66k in Stock

Company: AEHR TEST SYSTEMS (AEHR) Form: 144 | Filed: 2025-10-09 Significance: Low

Insider: DANESH FARIBA Title: Director | Relationship: Director

Transaction (Proposed): • Type: Sale • Shares: 2,665 • Approx. Price: $24.87 • Value: $66,278 • Owned After: Not Disclosed

Key Insight: A director has filed a notice of proposed sale for a small portion of stock, valued at approximately $66k. The shares were originally acquired as compensation.

Market Context: This is a Form 144, indicating an intent to sell within the next 90 days, not a completed transaction. The small size suggests it is likely for personal liquidity or portfolio management rather than a change in outlook on the company.

View Full Filing

This is PUBLIC SEC data for educational purposes. Not investment advice.

Comprehensive Analysis

SEC Filing Analysis: AEHR TEST SYSTEMS (AEHR)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: A director of AEHR Test Systems has filed a Form 144, indicating their intent to sell approximately $66,278 worth of common stock. The small size of the proposed sale suggests it is not a significant event.
  • Market Impact: The market impact is expected to be neutral. The transaction value is minor for a corporate director and is unlikely to influence investor sentiment or stock price.

Company Information

FieldValue
CompanyAEHR TEST SYSTEMS
Ticker SymbolAEHR
CIK0001040470
IndustryInstruments for Meas & Testing of Electricity & Elec Signals

Insider Information

FieldValue
NameDANESH FARIBA
CIK0001228855
Title/PositionDirector
RelationshipDirector

Transaction Details

FieldValue
Form Type144 (Notice of Proposed Sale)
Transaction Date2025-10-09 (Approximate Sale Date)
Transaction CodeNot Applicable
Security TypeCommon Stock
Shares Involved2,665
Price Per Share~$24.87 (Calculated from Aggregate Value)
Total Value$66,278.00
Shares Owned AfterNot Disclosed
Ownership TypeNot Disclosed

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: A Form 144 filing for a sale of this size is a routine disclosure. The value is insignificant relative to the company's market capitalization and the insider's likely total holdings. It does not signal a lack of confidence from the insider.

Volume & Sentiment

  • Expected Volume Impact: Negligible. The 2,665 shares will be easily absorbed by the market without a noticeable impact on trading volume.
  • Sentiment Indicator: Neutral. This type of filing is common and typically viewed as a non-event by the market unless the size is exceptionally large or part of a pattern of selling by multiple insiders.

Investment Insights

Positive Market Indicators

  • The filing is a standard regulatory requirement, indicating transparency.

Risk Factors

  • No significant risk factors are presented by this filing alone.

Key Takeaways

  1. Routine Filing: This is a Form 144, a notice of intent to sell restricted securities, not a confirmation of a completed sale.
  2. Low Financial Impact: The total value of $66,278 is minor and suggests the sale is for personal financial planning (e.g., liquidity, diversification, tax obligations) rather than a strategic move based on company performance.
  3. Compensation-Based Shares: The filing notes the shares were originally acquired as 'Compensation'. Selling shares received as part of a compensation package is a very common practice for executives and directors and is not typically considered a bearish signal.

Contextual Analysis

Timing Significance

  • The filing provides an 'approximate sale date' of October 9, 2025. Under Rule 144, the insider has a 90-day window from the filing date to execute the sale. The timing does not appear to be correlated with any major negative news.

Transaction Context

  • This is not an open-market transaction in the typical sense but a proposed sale of restricted stock. The filing fulfills the public notice requirements for such a sale.

Company Context

  • AEHR Test Systems operates in the semiconductor test and measurement industry. Analysis of this filing should be paired with a broader look at the company's recent earnings reports, industry trends, and overall financial health to form a complete picture.

Risk Assessment

Risk Level: Low

Risk Factors

  • This specific filing poses no material risk to investors.
  • The primary risk would be misinterpreting this routine filing as a significant bearish signal.

Market Considerations

  • Investors should monitor if this filing is followed by other, larger sales from the same or other insiders, as a pattern could be more meaningful.
  • The overall performance of the semiconductor sector is a more significant factor for AEHR's stock than this small insider transaction.

IMPORTANT DISCLAIMER: This analysis is for informational purposes only and is not intended as investment advice. The information presented is based on publicly available SEC filings and should not be construed as a recommendation to buy, sell, or hold any securities. Past performance does not guarantee future results. All investments carry risk, including the potential loss of principal. Please consult with a qualified financial advisor before making any investment decisions.

Analysis generated on 2025-10-09 | Data source: SEC EDGAR

Topics:#SECFiling#InsiderTrading#AEHR#AehrTestSystems#Form144#InsiderSell#StockMarket#Investing#DirectorTrade#MarketAnalysis

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.